Intratracheal hinokitiol injection decreases bacterial load in BALF and serum. by Toshihito Isono (8587668)

Hypoxia dramatically decreased cGMP in cultured porcine retina. by Lorena Olivares-González (3352898)

EC-SOD is decreased in the pulmonary artery in response to chronic hypoxia. by Tanya Hartney (15297)

CXCL12 expression results in decreased proliferation of PDAC cells. by Ishan Roy (530438)

“…<p>Population growth of adherent GFP and CXCL12-expressing MiaPaCa2 cells was assessed using the Viacount reagent and flow cytometric cell counting (A–B). CXCL12-expressing cells starved for 24 hours and cultured in both 0% serum (A) or 1% serum (B) containing medium were found to have decreased population growth.…”

Decreased oligodendrocyte precursor number in developing white matter tracts. by Mark D. Grier (726986)

Absence of FumC leads to decreased susceptibility to bactericidal antibiotics. by Stephanie D. Himpsl (8501868)

Ru-NO plus propolis decreased protein nitration at the lesion site. by Milena Menegazzo Miranda (739250)

Loperamide decreases mechanical responsiveness of unmyelinated, nociceptive C-fibers. by Matthias Ringkamp (253465)

“…Dashed line indicates threshold assigned to afferents unresponsive to 25 g vF hair. B) Loperamide dose-dependently decreases the responsiveness to suprathreshold mechanical stimuli in both animal groups (ANOVA lesion: F_(3,35) = 10.3, p<0.001; ANOVA sham: F_(3,16) = 4.5, p<0.05). …”

Inhibition of the lysosomal protease decreased the apoptosis induced by EV71. by Xueyan Xi (5654083)

Retinoschisin secretion into the conditioned medium is decreased by addition of cytochalasin D. by Eiko Kitamura (349087)

“…(D) Retinoschisin secretion decreases in a dose-dependent manner by treatment of cells with cytochalasin D at concentrations between 0.5 µM and 2 µM. …”

Afatinib decreases MAPK and AKT activation after MET knockdown. by Karolin Ebert (7434713)

Vasopressin decreases EPSPs in CA2 after LTP induction. by Magda Chafai (295116)

“…Values are expressed as % of the mean of the responses recorded during 5 min before AVP application. …”

SPL decreases diabetes-induced oxidative stress in GL and PT. by Eduardo Molina-Jijón (4020464)

“…Similar results were found between CTL and SPL groups. Data are mean±SEM from 5–6 rats per group. *p<0.05; **p<0.01 and ***p<0.001.…”

h-GAAP Decreases Cell Susceptibility to Intrinsic Apoptosis Pathways by Caroline Gubser (24818)

mTOR activity is decreased in KSR1-deficient T cells. by Marie Le Borgne (337225)

Treatment with tnv-1 decreases growth of NSCLC cell lines. by Ivana Grbesa (730814)

PR-619 decreases Smad4 expression in UUO mice. by Kotaro Soji (5638613)

Video_7_Contribution of 5-HT2 Receptors to the Control of the Spinal Locomotor System in Intact Rats.WMV by Henryk Majczyński (830716)

“…Little is known about the role of 5-HT receptors in the control of voluntary locomotion, so we administered inverse agonists of 5-HT₂ (Cyproheptadine; Cypr), 5-HT_2A neutral antagonist (Volinanserin; Volin), 5-HT_2C neutral antagonist (SB 242084), and 5-HT_2B/2C inverse agonist (SB 206553) receptors intrathecally in intact rats and monitored their effects on unrestrained locomotion. …”

Image_3_Contribution of 5-HT2 Receptors to the Control of the Spinal Locomotor System in Intact Rats.JPEG by Henryk Majczyński (830716)

“…Little is known about the role of 5-HT receptors in the control of voluntary locomotion, so we administered inverse agonists of 5-HT₂ (Cyproheptadine; Cypr), 5-HT_2A neutral antagonist (Volinanserin; Volin), 5-HT_2C neutral antagonist (SB 242084), and 5-HT_2B/2C inverse agonist (SB 206553) receptors intrathecally in intact rats and monitored their effects on unrestrained locomotion. …”

Image_2_Contribution of 5-HT2 Receptors to the Control of the Spinal Locomotor System in Intact Rats.JPEG by Henryk Majczyński (830716)

“…Little is known about the role of 5-HT receptors in the control of voluntary locomotion, so we administered inverse agonists of 5-HT₂ (Cyproheptadine; Cypr), 5-HT_2A neutral antagonist (Volinanserin; Volin), 5-HT_2C neutral antagonist (SB 242084), and 5-HT_2B/2C inverse agonist (SB 206553) receptors intrathecally in intact rats and monitored their effects on unrestrained locomotion. …”